Moderna's combination skin cancer therapy receives FDA's breakthrough tag
Moderna Inc said on Wednesday its experimental mRNA skin cancer vaccine in combination with Merck & Co Inc blockbuster drug Keytruda has received breakthrough therapy designation from the U.S.... | February 22, 2023